Aziz Eftekhari
1, Reza Heidari
2, Elham Ahmadian
3,4* , Mohammad Ali Eghbal
5*1 Pharmacology and Toxicology Department, Maragheh University of Medical Sciences, Maragheh, Iran.
2 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
3 Dental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
4 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
5 Pharmacology and Toxicology Department, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Background: Drug-induced
liver injury is a critical clinical complication. Hence, finding new and safe
protective agents with potential clinical application is of value. Isoniazid
(INH) is an antituberculosis agent widely used against Mycobacterium tuberculosis
infection in human. On the other hand, hepatotoxicity is a clinical
complication associated with isoniazid therapy. Oxidative stress and its
associated events are major mechanisms identified for INH-induced liver injury.
Carnosine is an endogenously found peptide widely investigated for its
hepatoprotective effects. On the other hand, robust antioxidant and
cytoprotective effects have been attributed to this peptide.
Methods: The
current study designed to evaluate the potential cytoprotective properties of
carnosine against INH-induced cytotoxicity in drug-exposed primary cultured rat
hepatocytes. Primary cultured rat hepatocytes were incubated with INH (1.2 mM).
Results: INH
treatment caused significant increase in cell death and lactate dehydrogenase
(LDH) release. On the other hand, it was found that markers of oxidative stress
including reactive oxygen species were significantly increased in INH-treated
cells. Cellular glutathione reservoirs were also depleted in INH-treated group.
Carnosine treatment (50 and 100 µM) significantly diminished INH-induced
oxidative stress and cytotoxicity.
Conclusion: These
data mention carnosine as a potential protective agent with therapeutic
capability against INH hepatotoxicity.